samedan logo
 
 
 
spacer
home > pmps > spring 2019 > making your mark
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Making Your Mark

Unique device identification (UDI) is a system used to identify medical devices entering the healthcare supply chain. Each device (and version or model thereof) will have a designated number assigned by the manufacturer or labeller which must be added in both machine- (Auto ID) and human-readable form to both the packaging and, in some cases, the device itself, provided doing so is required under the regulation. The rule also necessitates dates on medical device labels to conform to a standard format: day-month-year (eg, 30-09-2013) to ensure dates are unambiguous and clearly understood by device users. Standards have been developed by regulators, such as the FDA, to increase patient safety via the ability to effectively track devices through their distribution and use. In Europe, the European Commission has introduced the European Medical Devices Directive to ensure the health and safety of EU citizens is protected in this area (1).

As a globally recognised standard, every medical device manufacturer will be required to comply with the regulations, which state that a UDI must be included on device labels and packages, unless an exception or alternative is stated within the rules.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Thierry Protas is the Global Pharma Director at Videojet Technologies. He leads a dedicated global pharma team who support organisations and supply chain partners with coding solutions, certifications, and fast, reliable service. Thierry has spent the last 30 years in the pharma industry within different organisations. He started in the automation business where he used to work with the major pharma original equipment manufacturers, before moving to the coding industry as a CO2 laser expert, with pharma end-users being his key focus. Thierry then moved to brand protection to focus on pharma customers, providing them with multiple solutions to fight counterfeiting.
spacer
Thierry Protas
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Shionogi Announces Publication of Two Studies in The Lancet Infectious Diseases Highlighting The Efficacy And Safety of Cefiderocol For The Treatment of Infections Due to Aerobic Gram-Negative Bacteria in Adults With Limited Treatment Options

Shionogi announces publication of data from two of its clinical trials; APEKS-NP and CREDIBLE-CR in the journal The Lancet Infectious Diseases.
More info >>

White Papers

The Emerging Use of Social Media in Orphan Disease Drug Research

Worldwide Clinical Trials Ltd

The use of various social media platforms, such as Twitter, Instagram, Facebook, and LinkedIn, for dissemination of clinical trial information has created a cornucopia of possibilities enabling clinical trial performance. Characterized by a people-to-people immediacy, social media permits extraordinarily adaptive modification of study information in real-time, and it does so in a highly targeted fashion.
More info >>

 
Industry Events

World Vaccine Congress Europe

18-21 October 2020, Barcelona, Spain

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement